12-Week Study Assessing Change in Psoriasis Severity and Level of Stress Using TEN

Exclusion Criteria

• •Guttate, erythrodermic, or pustular psoriasis subtypes.
• •Evidence of skin conditions other than psoriasis that would interfere with study-related evaluations of psoriasis.
• •Unstable psoriasis or unstable treatment of psoriasis over the entire duration of the study.
• •Subjects with moderate psoriasis are not allowed to use concurrent systemic therapies for psoriasis (i.e., phototherapy, orals, biologics, etc.). Topical medications are allowed;
• •Subjects with severe psoriasis are allowed to use any concurrent therapy for psoriasis, provided that disease state is stable for ≥2 months and they meet minimum PASI requirements.
• •Cardiac pacemaker, implanted defibrillator, or other implanted metallic or electronic device.